Follow
Domenico Ciliberto
Domenico Ciliberto
AOU Mater Domini Catanzaro
Verified email at materdominiaou.it - Homepage
Title
Cited by
Cited by
Year
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials
D Ciliberto, C Botta, P Correale, M Rossi, M Caraglia, P Tassone, ...
European journal of cancer 49 (3), 593-603, 2013
1512013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients
C Botta, V Barbieri, D Ciliberto, A Rossi, D Rocco, R Addeo, N Staropoli, ...
Cancer biology & therapy 14 (6), 469-475, 2013
1012013
Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and meta-analysis of randomized controlled trials
D Ciliberto, U Prati, L Roveda, V Barbieri, N Staropoli, A Abbruzzese, ...
Oncology reports 27 (6), 1849-1856, 2012
962012
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET …
MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ...
Cancer biology & therapy 12 (9), 780-787, 2011
932011
Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?
I Cucinotto, L Fiorillo, S Gualtieri, M Arbitrio, D Ciliberto, N Staropoli, ...
Journal of Drug Delivery 2013, 2013
712013
Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials
N Staropoli, D Ciliberto, C Botta, L Fiorillo, A Grimaldi, S Lama, ...
Cancer biology & therapy 15 (6), 707-720, 2014
542014
Postinfectious functional gastrointestinal disorders in children: a multicenter prospective study
L Pensabene, V Talarico, D Concolino, D Ciliberto, A Campanozzi, ...
The Journal of Pediatrics 166 (4), 903-907. e1, 2015
522015
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic …
P Correale, C Botta, MS Rotundo, A Guglielmo, R Conca, A Licchetta, ...
Journal of Immunotherapy 37 (1), 26-35, 2014
522014
Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients
C Botta, D Ciliberto, M Rossi, N Staropoli, M Cuce, T Galeano, ...
Blood advances 1 (7), 455-466, 2017
512017
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival
C Botta, MT Di Martino, D Ciliberto, M Cuce, P Correale, M Rossi, ...
Blood cancer journal 6 (12), e511-e511, 2016
392016
The Era of PARP inhibitors in ovarian cancer:“Class Action” or not? A systematic review and meta-analysis
N Staropoli, D Ciliberto, T Del Giudice, E Iuliano, M Cucč, F Grillone, ...
Critical Reviews in Oncology/Hematology 131, 83-89, 2018
362018
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
D Ciliberto, N Staropoli, F Caglioti, S Gualtieri, L Fiorillo, S Chiellino, ...
Cancer biology & therapy 16 (8), 1148-1159, 2015
322015
Immunotherapy of colorectal cancer: new perspectives after a long path
P Correale, C Botta, D Ciliberto, P Pastina, R Ingargiola, S Zappavigna, ...
Immunotherapy 8 (11), 1281-1292, 2016
252016
The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis
D Ciliberto, N Staropoli, F Caglioti, S Chiellino, A Ierardi, R Ingargiola, ...
Critical reviews in oncology/hematology 125, 69-77, 2018
212018
Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer
D Ciliberto, N Staropoli, S Chiellino, C Botta, P Tassone, P Tagliaferri
Pancreatology 16 (2), 249-258, 2016
192016
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up
M Caraglia, P Correale, R Giannicola, N Staropoli, C Botta, P Pastina, ...
Frontiers in Oncology 9, 1102, 2019
152019
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine
P Correale, C Botta, N Staropoli, V Nardone, P Pastina, C Ulivieri, ...
Oncotarget 9 (29), 20539, 2018
122018
Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation
N Staropoli, D Ciliberto, S Chiellino, F Caglioti, T Del Giudice, S Gualtieri, ...
Oncotarget 7 (50), 82741, 2016
112016
Post-Infectious Functional Gastrointestinal Disorders Study Group of Italian Society for Pediatric Gastroenterology, Hepatology and Nutrition. Postinfectious functional …
L Pensabene, V Talarico, D Concolino, D Ciliberto, A Campanozzi, ...
J Pediatr 166 (4), 903-7, 2015
82015
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
N Staropoli, D Ciliberto, C Botta, L Fiorillo, S Gualtieri, A Salvino, ...
Journal of Ovarian Research 6 (1), 1-7, 2013
82013
The system can't perform the operation now. Try again later.
Articles 1–20